Abdul Hye

7.2k total citations · 1 hit paper
83 papers, 3.4k citations indexed

About

Abdul Hye is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Abdul Hye has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Physiology, 25 papers in Molecular Biology and 13 papers in Psychiatry and Mental health. Recurrent topics in Abdul Hye's work include Alzheimer's disease research and treatments (37 papers), Dementia and Cognitive Impairment Research (11 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Abdul Hye is often cited by papers focused on Alzheimer's disease research and treatments (37 papers), Dementia and Cognitive Impairment Research (11 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Abdul Hye collaborates with scholars based in United Kingdom, Sweden and United States. Abdul Hye's co-authors include Simon Lovestone, Henrik Zetterberg, Madhav Thambisetty, Kaj Blennow, Nicholas J. Ashton, Claire Troakes, Dag Aarsland, Michael Schöll, Thomas K. Karikari and Stuart G. Snowden and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Abdul Hye

78 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

2021 390 citations Nicholas J. Ashton, Thomas K. Karikari et al. profile →

Peers

Countries citing papers authored by Abdul Hye

Since Specialization

Citations

This map shows the geographic impact of Abdul Hye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Hye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Hye more than expected).

Fields of papers citing papers by Abdul Hye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul Hye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Hye. The network helps show where Abdul Hye may publish in the future.

Co-authorship network of co-authors of Abdul Hye

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul Hye. A scholar is included among the top collaborators of Abdul Hye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul Hye. Abdul Hye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial 2025 ·The Journal of Prevention of Alzheimer s Disease ·(unknown), Tim Whitfield, Harriet Demnitz‐King, Amanda Heslegrave, Géraldine Poisnel, Antoine Lutz, Éric Frison, Miranka Wirth, Abdul Hye, Frank Jessen, Nicholas J. Ashton, (unknown), Natalie L. Marchant	0
2	Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial 2023 ·Journal of NeuroVirology ·(unknown), Eric Decloedt, Henrik Zetterberg, Magnus Gisslén, Maia Lesosky, (unknown), Eleni Koutsilieri, Carsten Scheller, Abdul Hye, John A. Joska	3
3	Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome 2023 ·Parkinsonism & Related Disorders ·(unknown), Abdul Hye, Latha Velayudhan, B. Bloth, Panagiota Tsitsi, Ioanna Markaki, Per Svenningsson	11
4	Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease 2022 ·npj Parkinson s Disease ·Lucia Batzu, Silvia Rota, Abdul Hye, Amanda Heslegrave, Dhaval Trivedi, Lucy L. Gibson, Chloë Farrell, (unknown), Alexandra Rizos, Henrik Zetterberg, К. Ray Chaudhuri, Dag Aarsland	40
5	Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 2021 ·Parkinsonism & Related Disorders ·Andrea Pilotto, Alberto Imarisio, F. L. Conforti, Andrea Scalvini, Stefano Masciocchi, (unknown), Rosanna Turrone, Stefano Gipponi, Elisabetta Cottini, Barbara Borroni, Maria Cristina Rizzetti, Marina Pizzi, Laura Bonanni, Andrea Sturchio, Alberto J. Espay, Henrik Zetterberg, Nicholas J. Ashton, Abdul Hye, Alessandro Padovani	43
6	Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson’s Disease 2021 ·Neurodegenerative Diseases ·Alberto Imarisio, Andrea Pilotto, Emirena Garrafa, F. L. Conforti, Stefano Masciocchi, Rosanna Turrone, Stefano Gipponi, Elisabetta Cottini, Maria Cristina Rizzetti, Vanessa Porrini, Cristina Gussago, (unknown), Fiorella Guadagni, Henrik Zetterberg, Nicholas J. Ashton, Abdul Hye, Alessandro Padovani	6
7	A genome-wide association study of plasma phosphorylated tau181 2021 ·Neurobiology of Aging ·Jodie Lord, Anna Zettergren, Nicholas J. Ashton, Thomas K. Karikari, Andréa Lessa Benedet, Joel Simrén, Abdul Hye, Dag Aarsland, Kaj Blennow, Henrik Zetterberg, Petroula Proitsi	6
8	Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease 2021 ·Journal of Alzheimer s Disease ·Álex Handy, (unknown), Jodie Lord, Rebecca Green, Jin Xu, Dag Aarsland, Latha Velayudhan, Abdul Hye, Richard Dobson, Petroula Proitsi	6
9	Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease 2021 ·Alzheimer s Research & Therapy ·Luke Whiley, Katie Chappell, Ellie D’Hondt, Matthew R. Lewis, Beatriz Jiménez, Stuart G. Snowden, Hilkka Soininen, Iwona Kłoszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Jonathan R. Swann, Abdul Hye, Simon Lovestone, Cristina Legido‐Quigley, Elaine Holmes	84
10	The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population 2021 ·Scientific Reports ·Sarah E. Pape, (unknown), Nicholas J. Ashton, Abdul Hye, Rory Sheehan, Paul Gallagher, (unknown), (unknown), Ken Courtenay, Vesna Jordanova, (unknown), Perumal Nagarajan, (unknown), Angela Hassiotis, André Strydom	6
11	An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders 2020 ·Nature Reviews Neurology ·Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, (unknown), Marc Suárez‐Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg, Dag Aarsland	125
12	Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load 2020 ·Journal of Alzheimer s Disease ·Pratishtha Chatterjee, Maryam Mohammadi, Kathryn Goozee, Tejal Shah, Hamid R. Sohrabi, Cintia B. Dias, Kaikai Shen, Prita R. Asih, Preeti Dave, Steve Pedrini, Nicholas J. Ashton, Abdul Hye, Kevin Taddei, David B. Lovejoy, Henrik Zetterberg, Kaj Blennow, Ralph N. Martins	7
13	Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease 2020 ·Translational Neurodegeneration ·Jin Xu, (unknown), Min Kim, Asger Wretlind, Jodie Lord, Rebecca Green, Angela Hodges, Abdul Hye, Dag Aarsland, Latha Velayudhan, Richard Dobson, Petroula Proitsi, Cristina Legido‐Quigley	44
14	Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease 2019 ·Journal of Neuroinflammation ·Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas J. Ashton, Abdul Hye, Steve Pedrini, Hamid R. Sohrabi, Tejal Shah, Prita R. Asih, Preeti Dave, Kaikai Shen, Kevin Taddei, David B. Lovejoy, Gilles J. Guillemin, Kaj Blennow, Ralph N. Martins	52
15	No association of salivary total tau concentration with Alzheimer's disease 2018 ·Neurobiology of Aging ·Nicholas J. Ashton, Mark Ide, Michael Schöll, Kaj Blennow, Simon Lovestone, Abdul Hye, Henrik Zetterberg	55
16	Local Chemotherapy for Retinoblastoma 2017 ·Pakistan Journal of Ophthalmology ·(unknown), Abdul Hye	1
17	Pattern of Ocular trauma in Tertiary Care Hospital 2017 ·Pakistan Journal of Ophthalmology ·Hussain Ahmad Khaqan, (unknown), Sadia Ilyas, Abdul Hye	2
18	Plasma Transthyretin as a Candidate Marker for Alzheimer's Disease 2012 ·Journal of Alzheimer s Disease ·Latha Velayudhan, Richard Killick, Abdul Hye, Anna Kinsey, Andreas Güntert, Steven Lynham, Malcolm Ward, Rufina Leung, Anbarasu Lourdusamy, (unknown), John Powell, Simon Lovestone	77
19	Isolation of detergent resistant microdomains from cultured neurons: detergent dependent alterations in protein composition 2010 ·BMC Neuroscience ·Ritchie Williamson, Andrew Thompson, (unknown), Abdul Hye, Alessia Usardi, Steven Lynham, Brian H. Anderton, Diane P. Hanger	23
20	Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers 2007 ·Expert Review of Proteomics ·Simon Lovestone, Andreas Güntert, Abdul Hye, Steven Lynham, Madhav Thambisetty, Malcolm Ward	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact